Gustavo dos Santos Fernandes

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Mismatch Repair–Deficient Rectal Cancer and Resistance to Neoadjuvant Chemotherapy

Andrea Cercek, Gustavo dos Santos Fernandes, Campbell S.D. Roxburgh et al. · Clinical Cancer Research · 2020 · 239 citations

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers

Andrea Cercek, Walid K. Chatila, Rona Yaeger et al. · JNCI Journal of the National Cancer Institute · 2021 · 175 citations · Full text

Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation

Gustavo dos Santos Fernandes, Daniel M. Girardi, João Paulo Giacomini Bernardes et al. · BMC Cancer · 2018 · 79 citations · Full text

Cancer Deaths due to Lack of Universal Access to Radiotherapy in the Brazilian Public Health System

Lucas C. Mendez, Fábio Ynoe de Moraes, Gustavo dos Santos Fernandes et al. · Clinical Oncology · 2017 · 63 citations · Full text

Adaptive Radiotherapy, Radiation Medicine, Oncology +7